Back to search

Article

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host-Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by <i>Betacoronavirus</i>

2023-09-19

Abstract excerpt

Exacerbated inflammatory responses are a hallmark of severe coronavirus disease 2019 (COVID-19). Zileuton (Zi) is a selective inhibitor of 5-lipoxygenase, an enzyme involved in the production of several inflammatory/pro-resolving lipid mediators. Herein, we investigated the effect of Zi treatment in a severe acute respiratory syndrome (SARS) model. Mouse hepatitis virus (MHV)3-infected mice treated with Zi signifi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
017381e0-c886-5d81-bb49-acb2ab9d3f1b
DOI
10.20944/preprints202309.1267.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host-Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by <i>Betacoronavirus</i>DOI 10.20944/preprints202309.1267.v1
Select a neighboring publication to make it the new centre.